OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential of cannabinoids as treatments for autism spectrum disorders
Vera Nezgovorova, Casara Jean Ferretti, Bonnie P. Taylor, et al.
Journal of Psychiatric Research (2021) Vol. 137, pp. 194-201
Open Access | Times Cited: 14

Showing 14 citing articles:

Repetitive Restricted Behaviors in Autism Spectrum Disorder: From Mechanism to Development of Therapeutics
Junbin Tian, Xuping Gao, Li Yang
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 59

Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study
Micha Hacohen, Orit Stolar, Matitiahu Berkovitch, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 44

Advances in Zebrafish as a Comprehensive Model of Mental Disorders
Lei Wang, Fan Liu, Yimeng Fang, et al.
Depression and Anxiety (2023) Vol. 2023, pp. 1-48
Open Access | Times Cited: 24

Cannabis Pharmacogenomics: A Path to Personalized Medicine
Mariana Babayeva, Zvi G. Loewy
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 4, pp. 3479-3514
Open Access | Times Cited: 17

BEHAVIORAL AND TRANSCRIPTOMIC EFFECTS OF A NOVEL CANNABINOID ON A RAT VALPROIC ACID MODEL OF AUTISM
Sally Loomis, Dylan E. Da Silva, Ranjev Savopoulos, et al.
Neuropharmacology (2025), pp. 110450-110450
Closed Access

Lipid-Based Molecules on Signaling Pathways in Autism Spectrum Disorder
Kunio Yui, George Imataka, Shigemi Yoshihara
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9803-9803
Open Access | Times Cited: 17

Role of Brain Modulators in Neurodevelopment: Focus on Autism Spectrum Disorder and Associated Comorbidities
Ali Saad, Amal Akour, Abdulla Mahboob, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 612-612
Open Access | Times Cited: 15

Autism and associated disorders: cannabis as a potential therapy
Mariana Babayeva, Haregewein Assefa, Paramita Basu, et al.
Frontiers in Bioscience-Elite (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 14

The Evolving Role of Cannabidiol-Rich Cannabis in People with Autism Spectrum Disorder: A Systematic Review
Bilal Jawed, Jessica Elisabetta Esposito, Riccardo Pulcini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12453-12453
Open Access | Times Cited: 2

Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review
Rick Wilhiam de Camargo, Linério Ribeiro de Novais Júnior, Larissa Mendes da Silva, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 221, pp. 173492-173492
Closed Access | Times Cited: 8

Single and in combination antiepileptic drug therapy in children with epilepsy: how to use it
Claudia Oliva, Gloria Gangi, Silvia Marino, et al.
AIMS Medical Science (2021) Vol. 8, Iss. 2, pp. 138-146
Open Access | Times Cited: 6

Cannabis Compounds: Potential Therapy for Neurological Disease
Mariana Babayeva, Zvi G. Loewy
IntechOpen eBooks (2024)
Open Access

Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study
Micha Hacohen, Orit Stolar, Matitiahu Berkovitch, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1

Page 1

Scroll to top